Concepedia

Feng Yin

FY

14

Publications

521

Citations

12

H-Index

1999

Active since

Affiliations

Agios Pharmaceuticals (United States)(Current)

The Ohio State University

Pharmaceutical Product Development (United States)

Memorial Sloan Kettering Cancer Center

University of California, Los Angeles

Feng Yin is an author at Agios Pharmaceuticals (United States) specializing in medicine, pharmacology, and neurology.

Top concepts

Publications per year

1999–2023

14

Publications

14

Steroidogenic Enzyme AKR1C3 Is a Novel Androgen Receptor-Selective Coactivator that Promotes Prostate Cancer Growth

Muralimohan Yepuru, Zhongzhi Wu, Anand Kulkarni et al. · Clinical Cancer Research · 2013 · 119 citations

Alterations in chondroitin sulfate proteoglycan expression occur both at and far from the site of spinal contusion injury

Ellen M. Andrews, Rebekah J. Richards, Feng Yin et al. · Experimental Neurology · 2011 · 101 citations · Full text

, , +11

TGF-α increases astrocyte invasion and promotes axonal growth into the lesion following spinal cord injury in mice

Robin White, Feng Yin, Lyn B. Jakeman · Experimental Neurology · 2008 · 71 citations · Full text

, , +8

L1 cell adhesion molecule is essential for the maintenance of hyperalgesia after spinal cord injury

Emily L. Hoschouer, Feng Yin, Lyn B. Jakeman · Experimental Neurology · 2008 · 34 citations · Full text

, , +10

A phase I, open label, perioperative study of AG-120 and AG-881 in recurrent IDH1 mutant, low-grade glioma: Results from cohort 1.

Ingo K. Mellinghoff, Timothy F. Cloughesy, Patrick Y. Wen et al. · Journal of Clinical Oncology · 2019 · 33 citations

, , +24

Rows per page

1–5 of 14